Post-procedure Care:
After the ablation procedure, patients on warfarin received low
molecular weight heparin until an INR of 2.0–3.0 was achieved. Patients
previously treated with NOACs, underwent the ablation after skipping one
dose. The NOAC therapy was restarted between 3-5 hours post procedure.
Anticoagulation was continued for at least 3 months in patients with
CHA2DS2VASc 0–1 score or indefinitely in patients with CHA2DS2VASc of 2
or more. Antiarrhythmic therapy was restarted immediately after the
procedure and continued for 1 month.
The study protocol was approved by the local ethical committee and
registered in the Israel Ministry of Health (MOH 2020-06-22_009053).
Written informed consent was obtained from all study subjects. The data
that support the findings of this study are available from the
corresponding author upon reasonable request.